Wanhua Zhang

发表

Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy.

M. Shen, Zhuang Yang, Ming-hai Tang, 2019, European journal of medicinal chemistry.

Role of BCR-ABL1 isoforms on the prognosis of Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A meta-analysis

Wanhua Zhang, P. Kuang, Ting Liu, 2020, PloS one.

Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis

He Li, Wanhua Zhang, P. Kuang, 2017, Annals of Hematology.

Association of minimal residual disease with clinical outcomes in Philadelphia chromosome positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era: A systemic literature review and meta-analysis

Wanhua Zhang, E. Jang, 2021, PloS one.

Identification of a Novel 2,8-Diazaspiro[4.5]decan-1-one Derivative as a Potent and Selective Dual TYK2/JAK1 Inhibitor for the Treatment of Inflammatory Bowel Disease.

T. Yang, Zhuang Yang, Ming-hai Tang, 2022, Journal of medicinal chemistry.

Discovery of a Series of Hydroxamic Acid-Based Microtubule Destabilizing Agents with Potent Antitumor Activity.

Yan Liu, Zhuang Yang, Ming-hai Tang, 2021, Journal of medicinal chemistry.

Identification of Pyrrolo[2,3- d]pyrimidine-Based Derivatives as Potent and Orally Effective Fms-like Tyrosine Receptor Kinase 3 (FLT3) Inhibitors for Treating Acute Myelogenous Leukemia.

Yuquan Wei, Sheng-yong Yang, Mingli Xiang, 2019, Journal of Medicinal Chemistry.

Combination of IKZF1 deletion and early molecular response show significant roles on prognostic stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia patients

He Li, Wanhua Zhang, Yuhuan Zheng, 2018, Leukemia & lymphoma.

Prognostic significance of CDKN2A/B deletions in acute lymphoblastic leukaemia: a meta-analysis

Wanhua Zhang, P. Kuang, Ting Liu, 2019, Annals of medicine.

The first case of acute T-cell lymphoblastic leukemia containing the e19a2 BCR-ABL1 transcript: a durable molecular response using imatinib-based chemotherapy

Wanhua Zhang, Y. Ye, Yunfan Yang, 2017, Leukemia & lymphoma.

Screening ABL1 kinase domain mutations in patients with de novo Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL)

He Li, Wanhua Zhang, Y. Ye, 2017, Leukemia & lymphoma.

Validations of Top and Novel Susceptibility Variants in All-Age Chinese Patients With Acute Lymphoblastic Leukemia

Yuelan Wang, Wanhua Zhang, Y. Shu, 2020, Frontiers in Genetics.

Regulatory Network and Prognostic Effect Investigation of PIP4K2A in Leukemia and Solid Cancers

Wei Zhang, Hong Wang, Yuelan Wang, 2019, Front. Genet..

Discovery of Novel Dual Histone Deacetylase and Mammalian Target of Rapamycin Target Inhibitors as a Promising Strategy for Cancer Therapy.

Yuquan Wei, Sheng-yong Yang, F. Wang, 2019, Journal of Medicinal Chemistry.

SKLB-14b, a novel oral microtubule-destabilizing agent based on hydroxamic acid with potent anti-tumor and anti-multidrug resistance activities.

Zhuang Yang, Ming-hai Tang, Wanhua Zhang, 2022, Bioorganic chemistry.